January 22, 2015
| Throughout 2015 the Canadian Cancer Survivor Network (CCSN) will offer a series of webinars designed to provide you with information to help build your knowledge and understanding of medical marijuana use in Canada.
The first webinar in this series and the first webinar of 2015 was held on January 22nd at 1:00 PM EST and featured a presentation and QA session with Dr. Paul Daeninck , MD, MSc, FRCPC. |
|
| Dr. Daeninck is a Winnipeg oncologist at St. Boniface General Hospital and palliative care consultant with CancerCare Manitoba who specializes in the use of cannabinoids for medical purposes. Dr. Daeninck is assistant professor in the department of oncology at the University of Manitoba, the co-chair of pain and symptom research group at CancerCare Manitoba and a board member of The Canadian Consortium for the Investigation of Cannabinoids (CCIC).
At this webinar you will learn:
- Basic facts about medical cannabis
- The role of medical cannabis for cancer patients
A Q&A at the end of the presentation will be held allowing you the opportunity to ask your questions about medical cannabis use and availability in Canada. |
|
|
| Sponsored and supported by CannTrust Inc. (www.canntrust.ca) Canada’s only pharmacist owned and operated producer of medical cannabis. |
|
|
If you would like to access the slides from this presentation, please CLICK HERE.
